Scout | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)

This grant opportunity aims to fund early stage clinical trials for new drugs or devices targeting psychiatric disorders with unmet needs. It supports trials in both children and adults, focusing on safety, brain exposure, and effectiveness. The goal is to gather data to reduce the risks for further drug or device development and to attract additional funding. The grant emphasizes collaboratio…

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Submission Deadline: October 15, 2024

Application Window Closes: October 15, 2024

Opportunity Released: March 2, 2021

Open for Submission: March 2, 2021

Keywords

1. Early Stage Clinical Trials 2. Investigational Drugs 3. Novel Devices 4. Psychiatric Disorders 5. Pediatric Populations 6. Target Engagement 7. Pharmacological Effects 8. Safety and Tolerability 9. Phase II Proof of Concept 10. Collaborative Partnerships

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers